TOKAI Corp.
【Tokai】Full-Year 2026 Financial Results | Sales of ¥159.6 billion (YoY +6.8%)
For the fiscal year ending March 2026, consolidated sales reached ¥159.6 billion (up 6.8% YoY), setting a new record. Net income was ¥6.069 billion (up 28.3%), with strong performance across segments.
Key Figures
- Sales: ¥159.6 billion (up 6.8% YoY)
- Net income attributable to owners of parent: ¥6.069 billion (28.3% increase)
- Operating Income: ¥938.2 million (14.5% increase)
AI要約
Performance Overview
Tokai Co., Ltd. reported a record high for the fiscal year ending March 2026, with consolidated sales of ¥159.6 billion (up 6.8% YoY), operating income of ¥938.2 million (up 14.5%), ordinary income of ¥1,009.8 million (up 14.4%), and net income attributable to owners of parent of ¥6.069 billion (up 28.3%). M&A and expansion of new businesses contributed to steady performance across segments. Notably, health living services and pharmacy services performed well, supported by growth in the medical and healthcare-related sectors.
Outlook and Impact on Shareholders
Under its medium-term management plan, the company projects sales of ¥165.4 billion (up 3.6% YoY) and net income of ¥6.117 billion (up 0.8% YoY) for the fiscal year ending March 2027, continuing to promote profitability improvements and growth investments. Dividends are expected to increase by ¥10 to ¥68 per share. Shareholder returns will be strengthened through share buybacks and business expansion, aiming for long-term enhancement of corporate value.
Tokai Co., Ltd.
Company overview · Stock price · Financial data · All IR
